December 1, 2024 - 16:33

As the new administration approaches, industry experts are contemplating significant shifts in the cryptocurrency landscape. Mark Palmer, a Managing Director and Senior Research Analyst, recently shared his insights on potential regulatory changes that could reshape the sector.
Palmer highlighted the pressing need for a more structured approach to cryptocurrency regulation, contrasting it with the current strategy employed by the SEC under Gary Gensler. He criticized what he termed "regulation by enforcement," which has created uncertainty for institutional investors. This lack of a clear regulatory framework has deterred many from engaging with the burgeoning asset class, as they fear sudden interventions from federal regulators could jeopardize their projects.
The hope is that the incoming administration will usher in a more conducive environment for crypto, fostering institutional adoption and innovation. The anticipation surrounding these changes reflects a broader desire within the industry for clarity and stability, which could ultimately lead to a more robust and secure cryptocurrency market.
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...